Scarica l'app Stockscreener
0.9279
22.36%
0.1679
Dopo l'orario di chiusura:
.93
0.0021
+0.23%
Precedente Chiudi:
$0.76
Aprire:
$0.781
Volume 24 ore:
832.57K
Relative Volume:
8.18
Capitalizzazione di mercato:
$2.71M
Reddito:
$4.96M
Utile/perdita netta:
$-6.82M
Rapporto P/E:
-0.0142
EPS:
-65.4
Flusso di cassa netto:
$-6.64M
1 W Prestazione:
+4.34%
1M Prestazione:
-7.01%
6M Prestazione:
-55.51%
1 anno Prestazione:
-64.84%
Intervallo 1D:
$0.781
$0.9529
Intervallo di 1 settimana:
$0.7321
$0.9529
Portata 52W:
$0.7321
$7.98
Inmed Pharmaceuticals Inc Stock (INM) Company Profile
Nome
Inmed Pharmaceuticals Inc
Settore
Telefono
(604) 669-7207
Indirizzo
1445-885 WEST GEORGIA ST., VANCOUVER
Compare INM vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INM
Inmed Pharmaceuticals Inc
|
0.9279 | 2.22M | 4.96M | -6.82M | -6.64M | -65.40 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
125.96 | 53.16B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.47 | 47.25B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.91 | 37.59B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
490.21 | 21.85B | 3.13B | 1.27B | 1.12B | 26.39 |
Inmed Pharmaceuticals Inc Borsa (INM) Ultime notizie
INM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Can InMed Pharmaceuticals Inc. reach all time highs this yearQuarterly Performance Summary & Technical Confirmation Trade Alerts - mfd.ru
Risk Off: Can InMed Pharmaceuticals Inc be the next market leaderMarket Trend Report & Daily Volume Surge Signals - baoquankhu1.vn
INM Should I Buy - Intellectia AI
Published on: 2026-02-27 15:19:59 - baoquankhu1.vn
Is InMed Pharmaceuticals Inc. undervalued by DCF analysis2025 Bull vs Bear & Safe Capital Growth Stock Tips - mfd.ru
Is InMed Pharmaceuticals Inc. (MWG) stock a contrarian opportunity2025 Market Outlook & Safe Entry Momentum Tips - mfd.ru
INM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Aug Movers: Is InMed Pharmaceuticals Inc undervalued by DCF analysisMarket Weekly Review & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
InMed Highlights Q2 Results Amid Cash, Regulatory Pressures - TipRanks
InMed Pharmaceuticals Inc Reports Q2 2026 Financial Results and Business Update - TradingView
InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update - Investing News Network
InMed Pharmaceuticals Inc. SEC 10-Q Report - TradingView
What analysts say about InMed Pharmaceuticals Inc. stockJuly 2025 Fed Impact & Verified Stock Trade Ideas - mfd.ru
What drives InMed Pharmaceuticals Inc.’s stock priceGlobal Markets & Verified Entry Point Detection - mfd.ru
Will InMed Pharmaceuticals Inc stock go up in YEAR2025 Key Highlights & Safe Entry Zone Identification - baoquankhu1.vn
Nasdaq Moves: What analysts say about InMed Pharmaceuticals Inc stockTrend Reversal & Growth Focused Investment Plans - baoquankhu1.vn
Can InMed Pharmaceuticals Inc. stock double in the next yearJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - mfd.ru
Aug Summary: Will InMed Pharmaceuticals Inc. stock go up in YEARJuly 2025 Selloffs & Weekly Chart Analysis and Guides - mfd.ru
Should I add InMed Pharmaceuticals Inc. stock to my portfolio2025 Geopolitical Influence & Weekly High Return Stock Opportunities - mfd.ru
Risk Analysis: What drives InMed Pharmaceuticals Incs stock price2025 Support & Resistance & Momentum Based Trading Ideas - baoquankhu1.vn
InMed faces challenges from new US legislation - MSN
Chart Watch: What analysts say about InMed Pharmaceuticals Inc stockWeekly Trading Summary & Precise Buy Zone Identification - baoquankhu1.vn
Market Catalysts: What analysts say about InMed Pharmaceuticals Inc stockBull Run & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Aug PostEarnings: Does Nano X Imaging Ltd align with a passive investing strategy - baoquankhu1.vn
Performance Recap: Is InMed Pharmaceuticals Inc undervalued by DCF analysisWeekly Profit Analysis & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Breakout Zone: Can InMed Pharmaceuticals Inc stock surprise with earnings upsideJuly 2025 Big Picture & Safe Capital Investment Plans - Bộ Nội Vụ
Returns Recap: Can InMed Pharmaceuticals Inc. stock beat analyst upgrades2025 Technical Overview & Consistent Profit Alerts - Улправда
Will InMed Pharmaceuticals Inc. (MWG) stock beat revenue estimates2025 Year in Review & Growth Focused Entry Reports - Улправда
Pullback Watch: Can InMed Pharmaceuticals Inc. stock beat analyst upgradesOptions Play & Weekly Watchlist for Hot Stocks - Улправда
What dividend safety score for InMed Pharmaceuticals Inc. stockQuarterly Earnings Review & Budget Friendly Portfolio - Улправда
InMed Pharmaceuticals (NASDAQ:INM) Trading Up 5% – Time to Buy? - Defense World
Indian Infotech and Software Limited At Critical Juncture Bounce or BreakdownGlobal Trade Effects & Budget Friendly Portfolio Growth - earlytimes.in
Risk Check: Can InMed Pharmaceuticals Inc. stock outperform in 2025 bull market - Улправда
Surprises Report: What Wall Street predicts for InMed Pharmaceuticals Inc. stock price2025 Momentum Check & Advanced Technical Analysis Signals - Улправда
Growth Value: Why hedge funds are buying InMed Pharmaceuticals Inc. stock2025 Bull vs Bear & Real-Time Price Movement Reports - Улправда
Can InMed Pharmaceuticals Inc. stock outperform in 2025 bull marketQuarterly Market Summary & Stepwise Trade Signal Implementation - Улправда
Day Trade: How analysts revise price targets for InMed Pharmaceuticals Inc. (MWG) stockJuly 2025 Patterns & Stepwise Entry and Exit Trade Signals - Улправда
Why hedge funds are buying InMed Pharmaceuticals Inc. stockJuly 2025 Trends & Stepwise Entry and Exit Trade Signals - Улправда
InMed Shareholders Approve Directors and Equity Financing Flexibility - TipRanks
InMed Pharmaceuticals (INM) investors approve directors, auditor and 20%+ SEPA share issuance - Stock Titan
InMed Announces Results of 2025 Annual General and Special Meeting - Investing News Network
Drug developer's investors sign off on potential 20% new share issuance - Stock Titan
InMed Pharmaceuticals (INM) director details employee stock option expiry - Stock Titan
InMed Pharmaceuticals (INM) CEO Eric Adams details 250-option expiry - Stock Titan
InMed Pharmaceuticals Inc. (INM) discloses COO stock option expiration - Stock Titan
InMed Pharmaceuticals (INM) reports senior VP employee option expiration - Stock Titan
InMed to Discuss Its Pharmaceutical Pipeline and 2024 Strategic Priorities in Fireside Chat with Water Tower Research on January 25, 2024 at 1pm ET - TMX Newsfile
InMed to Present INM-901 Data at Alzheimer's Association International Conference (AAIC) 2025 - TMX Newsfile
Dated alerts on InMed Pharmaceuticals withdrawn - marketscreener.com
InMed Faces Challenges from New U.S. Legislation - TipRanks
Inmed Pharmaceuticals Inc Azioni (INM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.18%
1.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):